Alex De Caluwé

918 total citations · 1 hit paper
25 papers, 523 citations indexed

About

Alex De Caluwé is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Alex De Caluwé has authored 25 papers receiving a total of 523 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 12 papers in Cancer Research and 11 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Alex De Caluwé's work include Breast Cancer Treatment Studies (10 papers), Cancer Immunotherapy and Biomarkers (9 papers) and Advanced Radiotherapy Techniques (6 papers). Alex De Caluwé is often cited by papers focused on Breast Cancer Treatment Studies (10 papers), Cancer Immunotherapy and Biomarkers (9 papers) and Advanced Radiotherapy Techniques (6 papers). Alex De Caluwé collaborates with scholars based in Belgium, France and Canada. Alex De Caluwé's co-authors include Laurence Buisseret, Véronique Debien, Xiaoxiao Wang, Emanuela Romano, Martine Piccart, Vincent K. Tuohy, Fred Hsu, Alan Nichol, Cheryl Ho and David W. Anderson and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Annals of Oncology.

In The Last Decade

Alex De Caluwé

25 papers receiving 514 citations

Hit Papers

Immunotherapy in breast cancer: an overview of current st... 2023 2026 2024 2023 50 100 150 200
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Immunotherapy in breast cancer: an overview of current strategies and perspectives
    2023 202 citations Véronique Debien, Alex De Caluwé et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alex De Caluwé Belgium 9 305 196 116 104 100 25 523
Cesar E. Ochoa Australia 10 239 0.8× 128 0.7× 232 2.0× 135 1.3× 76 0.8× 13 502
Chuanben Chen China 14 235 0.8× 176 0.9× 65 0.6× 158 1.5× 74 0.7× 61 539
Minsig Choi United States 14 360 1.2× 134 0.7× 60 0.5× 190 1.8× 104 1.0× 28 549
Monika Devanaboyina United States 5 182 0.6× 81 0.4× 113 1.0× 153 1.5× 117 1.2× 9 451
Danae Hamouda United States 11 230 0.8× 67 0.3× 81 0.7× 156 1.5× 54 0.5× 33 460
Elena Tornari Italy 9 244 0.8× 71 0.4× 108 0.9× 161 1.5× 55 0.6× 12 431
Marcello Curvietto Italy 10 434 1.4× 108 0.6× 239 2.1× 180 1.7× 26 0.3× 29 618
Millie Das United States 17 405 1.3× 388 2.0× 35 0.3× 287 2.8× 145 1.4× 63 719
Angel Qin United States 12 343 1.1× 201 1.0× 94 0.8× 178 1.7× 122 1.2× 33 561

Countries citing papers authored by Alex De Caluwé

Since Specialization
Citations

This map shows the geographic impact of Alex De Caluwé's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alex De Caluwé with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alex De Caluwé more than expected).

Fields of papers citing papers by Alex De Caluwé

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alex De Caluwé. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alex De Caluwé. The network helps show where Alex De Caluwé may publish in the future.

Co-authorship network of co-authors of Alex De Caluwé

This figure shows the co-authorship network connecting the top 25 collaborators of Alex De Caluwé. A scholar is included among the top collaborators of Alex De Caluwé based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alex De Caluwé. Alex De Caluwé is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Arecco, Luca, Gabriella Gentile, Matteo Lambertini, et al.. (2025). Immunotherapy in the neoadjuvant treatment of hormone receptor-positive/HER2-negative early breast cancer: novel approaches and future perspectives. Current Opinion in Oncology. 37(6). 552–561. 1 indexed citations
2.
Caluwé, Alex De, Kim Cao, Vincent Remouchamps, et al.. (2025). Adapting radiation therapy to immunotherapy: Delineation and treatment planning of pre-operative immune-modulating breast iSBRT in 151 patients treated in the randomized phase II Neo-CheckRay trial. Radiotherapy and Oncology. 206. 110836–110836. 2 indexed citations
3.
4.
Caluwé, Alex De, et al.. (2024). Automated segmentation in planning-CT for breast cancer radiotherapy: A review of recent advances. Radiotherapy and Oncology. 202. 110615–110615. 3 indexed citations
5.
Wang, Xiaoxiao, L. Collet, Mattia Rediti, et al.. (2023). Predictive Biomarkers for Response to Immunotherapy in Triple Negative Breast Cancer: Promises and Challenges. Journal of Clinical Medicine. 12(3). 953–953. 33 indexed citations
6.
Tramm, Trine, Shane R. Stecklein, Navita Somaiah, et al.. (2023). Individualising radiation therapy decisions in breast cancer patients based on tumour infiltrating lymphocytes and genomic biomarkers. The Breast. 71. 13–21. 5 indexed citations
7.
Rodriguez, Diana, et al.. (2022). Inter-fraction heart displacement during voluntary deep inspiration breath hold radiation therapy without visual feedback measured by daily CBCT. Frontiers in Oncology. 12. 936088–936088. 5 indexed citations
8.
Philippson, C., Stéphane Simon, Alex De Caluwé, et al.. (2022). Intraoperative electron radiotherapy in early invasive ductal breast cancer: 6-year median follow-up results of a prospective monocentric registry. Breast Cancer Research. 24(1). 83–83. 3 indexed citations
9.
Caluwé, Alex De, Emanuela Romano, Andrea Gombos, et al.. (2022). 98P Neo-CheckRay, radiation therapy and adenosine pathway blockade to potentiate benefit of immuno-chemotherapy in early stage luminal B breast cancer: Results of the safety run-in phase. Annals of Oncology. 33. S170–S170. 1 indexed citations
10.
Deseyne, Pieter, Chris Monten, Vincent Remouchamps, et al.. (2021). Delineation guidelines for the lymphatic target volumes in ‘prone crawl’ radiotherapy treatment position for breast cancer patients. Scientific Reports. 11(1). 22529–22529. 2 indexed citations
11.
Caluwé, Alex De, et al.. (2021). Split-VMAT technique to control the deep inspiration breath hold time for breast cancer radiotherapy. Radiation Oncology. 16(1). 77–77. 5 indexed citations
12.
Caluwé, Alex De, Laurence Buisseret, Philip Poortmans, et al.. (2021). Neo-CheckRay: radiation therapy and adenosine pathway blockade to increase benefit of immuno-chemotherapy in early stage luminal B breast cancer, a randomized phase II trial. BMC Cancer. 21(1). 899–899. 23 indexed citations
13.
Jaeghere, Emiel A. De, Sandra Tuyaerts, An M. T. Van Nuffel, et al.. (2021). 159P Pembrolizumab, SBRT, and immunomodulation for recurrent and/or refractory cervical or endometrial carcinoma. Annals of Oncology. 32. S1449–S1450. 1 indexed citations
14.
Meattini, Icro, Matteo Lambertini, Isacco Desideri, et al.. (2019). Radiation therapy for young women with early breast cancer: Current state of the art. Critical Reviews in Oncology/Hematology. 137. 143–153. 13 indexed citations
15.
Tuyaerts, Sandra, An M. T. Van Nuffel, Eline Naert, et al.. (2019). PRIMMO study protocol: a phase II study combining PD-1 blockade, radiation and immunomodulation to tackle cervical and uterine cancer. BMC Cancer. 19(1). 506–506. 49 indexed citations
16.
Caluwé, Alex De, et al.. (2018). Dose-response in choroidal melanoma. Radiotherapy and Oncology. 127(3). 374–378. 3 indexed citations
17.
18.
19.
Hsu, Fred, et al.. (2017). Patterns of Spread and Prognostic Implications of Lung Cancer Metastasis in an Era of Driver Mutations. Current Oncology. 24(4). 228–233. 26 indexed citations
20.
Hsu, Fred, et al.. (2016). EGFR mutation status on brain metastases from non-small cell lung cancer. Lung Cancer. 96. 101–107. 92 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Cesar E. Ochoa Breakdown of academic impact, for papers by Chuanben Chen Breakdown of academic impact, for papers by Minsig Choi Breakdown of academic impact, for papers by Monika Devanaboyina Breakdown of academic impact, for papers by Danae Hamouda Breakdown of academic impact, for papers by Elena Tornari Breakdown of academic impact, for papers by Marcello Curvietto Breakdown of academic impact, for papers by Millie Das Breakdown of academic impact, for papers by Angel Qin
Rankless by CCL
2026